Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析

◆英語タイトル:Tiziana Life Sciences Plc (TILS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81774FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Tiziana Life Sciences Plc (TILS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical-stage biotechnology company that discovers and develops drugs to treat inflammatory diseases and cancers. The company’s lead product candidate, Milciclib (TZLS-201), intended for the treatment of thymic carcinoma. Its other clinical programs includes Foralumab (TZLS-401), a human engineered anti-human CD3 antibody intended for the treatment of Crohn’s disease and Nonalcoholic steatohepatitis. The company’s preclinical stage candidates include TZLS-501, a fully human anti-IL-6R monoclonal antibody targeting the interleukin-6 receptor; and StemPrintER, a multi-gene signature assay intended for the treatment of patients with breast cancer. Tiziana is headquartered in London, the UK.

Tiziana Life Sciences Plc Key Recent Developments

Aug 27,2020: Tiziana Life Sciences CEO updates shareholders on its patent portfolio, clinical pipeline, and strategy in an exclusive interview
Aug 20,2020: Tiziana is pleased to retain Dr. Napoleone Ferrara to serve on its Scientific Advisory Board for an additional three-year term
Jul 20,2020: Tiziana Life Sciences : Director appointment
Jun 18,2020: Tiziana Life Sciences directorate change
Jun 18,2020: Tiziana Life Sciences : Final results for the year ended 31 December 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Tiziana Life Sciences Plc – Key Facts
Tiziana Life Sciences Plc – Key Employees
Tiziana Life Sciences Plc – Key Employee Biographies
Tiziana Life Sciences Plc – Major Products and Services
Tiziana Life Sciences Plc – History
Tiziana Life Sciences Plc – Company Statement
Tiziana Life Sciences Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Tiziana Life Sciences Plc – Business Description
R&D Overview
Tiziana Life Sciences Plc – SWOT Analysis
SWOT Analysis – Overview
Tiziana Life Sciences Plc – Strengths
Tiziana Life Sciences Plc – Weaknesses
Tiziana Life Sciences Plc – Opportunities
Tiziana Life Sciences Plc – Threats
Tiziana Life Sciences Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Tiziana Life Sciences Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 27, 2020: Tiziana Life Sciences CEO updates shareholders on its patent portfolio, clinical pipeline, and strategy in an exclusive interview
Aug 20, 2020: Tiziana is pleased to retain Dr. Napoleone Ferrara to serve on its Scientific Advisory Board for an additional three-year term
Jul 20, 2020: Tiziana Life Sciences : Director appointment
Jun 18, 2020: Tiziana Life Sciences directorate change
Jun 18, 2020: Tiziana Life Sciences : Final results for the year ended 31 December 2019
Jan 21, 2020: Tiziana Life Sciences announces appointment of Mr. Gregor MacRae to strengthen the board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Tiziana Life Sciences Plc, Key Facts
Tiziana Life Sciences Plc, Key Employees
Tiziana Life Sciences Plc, Key Employee Biographies
Tiziana Life Sciences Plc, Major Products and Services
Tiziana Life Sciences Plc, History
Tiziana Life Sciences Plc, Other Locations
Tiziana Life Sciences Plc, Subsidiaries
Tiziana Life Sciences Plc, Key Competitors
Tiziana Life Sciences Plc, Ratios based on current share price
Tiziana Life Sciences Plc, Annual Ratios
Tiziana Life Sciences Plc, Annual Ratios (Cont...1)
Tiziana Life Sciences Plc, Interim Ratios
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Tiziana Life Sciences Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tiziana Life Sciences Plc (TILS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magnetek Inc:企業の戦略的SWOT分析
    Magnetek Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • The Quaker Oats Company:企業の戦略・SWOT・財務情報
    The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report Summary The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Malakoff Corporation Bhd (MALAKOF):電力:M&Aディール及び事業提携情報
    Summary Malakoff Corporation Bhd (Malakoff), a subsidiary of MMC Corporation Berhad, is an independent power and water producer. It generates electricity and desalinates water. The company also provides technical, simulator training, and overhaul services for CCGT, OCGT and coal-fired, multi-stage f …
  • Arotech Corporation:企業の戦略・SWOT・財務情報
    Arotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Arotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gulf Power Co:発電所・企業SWOT分析
    Gulf Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • CritiTech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CritiTech Inc (CritiTech) is a pharmaceutical contract development manufacturing organization that specializes in particle engineering, material characterization, analytical testing, early stage drug development, pre-clinical and clinical manufacturing. The company uses Spray Drying and Supe …
  • Ambac Financial Group Inc (AMBC):企業の財務・戦略的SWOT分析
    Ambac Financial Group Inc (AMBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Arden Partners Plc (ARDN):企業の財務・戦略的SWOT分析
    Summary Arden Partners Plc (Arden) is a multi-service stockbroker that provides a range of financial services to corporate and institutional clients. The company offers research, distribution, execution and corporate finance services. Arden distribution services include providing unique trading thou …
  • Novanta Inc (NOVT):企業の財務・戦略的SWOT分析
    Novanta Inc (NOVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ichor Holdings Ltd (ICHR):企業の財務・戦略的SWOT分析
    Ichor Holdings Ltd (ICHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PIK-Group:企業のM&A・事業提携・投資動向
    PIK-Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PIK-Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Edison SpA (EDNR):企業の財務・戦略的SWOT分析
    Edison SpA (EDNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tereos SA:企業の戦略的SWOT分析
    Tereos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • WIV Wein International AG:企業の戦略・SWOT・財務分析
    WIV Wein International AG - Strategy, SWOT and Corporate Finance Report Summary WIV Wein International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie) is a chemical company that manufactures and markets high performance polymers and specialty chemicals. The company's products include bonding products, polyamides, damping systems, sealants, coating products, thermoplastic material, technical fibers, and te …
  • SiteOne Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary SiteOne Therapeutics Inc (SiteOne) is a biopharmaceutical company that develops novel non-opioid pain therapeutics for the treatment of acute and chronic pain. The company’s lead therapeutic candidates include ST-2427 Intravenous, for post-operative pain; ST-SubQ Subcutaneous and ST-Oral, fo …
  • Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also pro …
  • L’Oreal SA:企業のM&A・事業提携・投資動向
    L'Oreal SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's L'Oreal SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • San Miguel Brewery Inc:企業の戦略・SWOT・財務情報
    San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report Summary San Miguel Brewery Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Grasim Industries Limited:企業の戦略・SWOT・財務情報
    Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆